News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,363 Results
Type
Article (87597)
Company Profile (823)
Press Release (775924)
Multimedia
Podcasts (181)
Webinars (28)
Section
Business (233130)
Career Advice (4140)
Deals (39821)
Drug Delivery (141)
Drug Development (91305)
Employer Resources (203)
FDA (18308)
Job Trends (17411)
News (397552)
Policy (39933)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (151)
Alzheimer's disease (1698)
Antibody-drug conjugate (ADC) (277)
Approvals (18357)
Artificial intelligence (538)
Autoimmune disease (115)
Automation (31)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (171)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (537)
Cancer (4295)
Cardiovascular disease (382)
Career advice (3562)
Career pathing (38)
CAR-T (262)
CDC (57)
Cell therapy (726)
Cervical cancer (33)
Clinical research (76033)
Collaboration (1482)
Company closure (4)
Compensation (990)
Complete response letters (64)
COVID-19 (2967)
CRISPR (88)
C-suite (649)
Cystic fibrosis (143)
Data (5223)
Decentralized trials (2)
Denatured (66)
Depression (121)
Diabetes (474)
Diagnostics (7123)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (253)
Drug pricing (197)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99739)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133834)
Executive appointments (1003)
FDA (20949)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1336)
Gene editing (187)
Generative AI (53)
Gene therapy (584)
GLP-1 (1053)
Government (5400)
Grass and pollen (8)
Guidances (375)
Healthcare (20941)
HIV (51)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (267)
Immuno-oncology (22)
Indications (61)
Infectious disease (3223)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (203)
Interviews (816)
IPO (17934)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (86)
Layoffs (648)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (14)
Lung cancer (607)
Lymphoma (297)
Machine learning (33)
Management (66)
Manufacturing (682)
MASH (160)
Medical device (14926)
Medtech (14958)
Mergers & acquisitions (22818)
Metabolic disorders (1236)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (244)
Neuropsychiatric disorders (72)
Neuroscience (2810)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (593)
Opinion (318)
Ovarian cancer (148)
Pain (173)
Pancreatic cancer (185)
Parkinson's disease (248)
Partnered (32)
Patents (439)
Patient recruitment (353)
Peanut (58)
People (66425)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23456)
Phase II (33001)
Phase III (24873)
Pipeline (3291)
Policy (310)
Postmarket research (3554)
Preclinical (10601)
Press Release (72)
Prostate cancer (209)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (725)
Real estate (7426)
Recruiting (80)
Regulatory (28221)
Reports (65)
Research institute (2702)
Resumes & cover letters (651)
Rett syndrome (20)
RNA editing (16)
RSV (78)
Schizophrenia (142)
Series A (219)
Series B (166)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4321)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (113)
Vaccines (1074)
Venture capital (70)
Weight loss (414)
Women's health (66)
Worklife (21)
Date
Today (193)
Last 7 days (943)
Last 30 days (3938)
Last 365 days (33589)
2025 (29899)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1286)
Alabama (83)
Alaska (7)
Arizona (314)
Arkansas (14)
Asia (51131)
Australia (8990)
California (10274)
Canada (3010)
China (974)
Colorado (432)
Connecticut (458)
Delaware (295)
Europe (117589)
Florida (1497)
Georgia (331)
Hawaii (3)
Idaho (68)
Illinois (846)
India (57)
Indiana (497)
Iowa (20)
Japan (345)
Kansas (129)
Kentucky (39)
Louisiana (28)
Maine (81)
Maryland (1358)
Massachusetts (7649)
Michigan (328)
Minnesota (601)
Mississippi (4)
Missouri (128)
Montana (33)
Nebraska (26)
Nevada (111)
New Hampshire (81)
New Jersey (2824)
New Mexico (32)
New York (2742)
North Carolina (1480)
North Dakota (10)
Northern California (4777)
Ohio (315)
Oklahoma (22)
Oregon (51)
Pennsylvania (2108)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (54)
South Dakota (1)
Southern California (3930)
Tennessee (157)
Texas (1599)
United States (37513)
Utah (308)
Virginia (259)
Washington D.C. (85)
Washington State (862)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 864,363 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A Quiet Revolution: How Pigs Are Bringing Hope to CDKL5 Families
November 14, 2025
·
1 min read
Layoffs
Bayer Layoffs Continued in Q3 but CEO Says Cuts Should Be ‘Incremental’ Moving Forward
Bayer has let go of about 13,500 employees, including around 5,000 managers, since implementing a new operating model in early 2024. CEO Bill Anderson said in a recent earnings call that he expects a slower rate of headcount reduction moving forward.
November 14, 2025
·
1 min read
·
Angela Gabriel
Press Releases
MMS Brings Biometrics and AI Leadership to PHUSE EU Connect 2025 and Previews Accepted Presentations for US Connect 2026
November 14, 2025
·
1 min read
Press Releases
AI In Healthcare Market to Hit USD 701.79 Billion by 2034
November 14, 2025
·
1 min read
Press Releases
Driving Biopharma Commercial Success through Redefined CRDMO Partnerships
Dr. Chris Chen, CEO of WuXi Biologics, answers questions about recent developments, novel platforms, and how to stay ahead of rapid developments to ensure quality, reliability and speed of delivery
November 14, 2025
·
1 min read
C-suite
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
“As the future chair I will attend to the interests of not only the Novo Nordisk Foundation but all shareholders of the company,” incoming chair and former Novo Nordisk CEO Lars Rebien Sørensen said at the meeting held Friday.
November 14, 2025
·
5 min read
·
Annalee Armstrong
Layoff Tracker
After $9.5B Blueprint Buyout, Sanofi Trims Preclinical Pipeline, Fires ‘Some’ Staff
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 14, 2025
·
84 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
A day after Pfizer closed its hotly contested Metsera deal, Lundbeck has made an unsolicited offer to steal Avadel Pharmaceuticals away from Alkermes.
November 14, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
At $9.2 billion, the Cidara acquisition lands among the top 5 largest deals of the year.
November 14, 2025
·
2 min read
·
Tristan Manalac
HIV
Gilead Looks To Simplify HIV Treatment By Combining Two Leading Drugs in One Pill
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV who are on complex treatment regimens, according to BMO Capital Markets.
November 14, 2025
·
2 min read
·
Tristan Manalac
1 of 86,437
Next
